Related Experiment Video
Updated: Jul 16, 2026
09:08
Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area
Published on: February 2, 2017
16.4K
SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury
Shunhui Wei1, Bo Chen1, See Wee Low1
1Calcium Signalling Laboratory, Department of Research, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
Molecular Neurobiology
|June 28, 2023
Summary
SLC26A11 facilitates chloride entry into neurons during stroke, causing swelling and edema. Inhibiting this pathway reduces stroke damage and improves recovery, offering a potential new therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Neuronal swelling is a key factor in stroke-induced cytotoxic edema.
- Hypoxia causes ion imbalance, leading to increased neuronal volume.
- The primary chloride entry pathway in neurons under hypoxic conditions remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of SLC26A11 as a major chloride entry pathway in neurons during hypoxia.
- To evaluate SLC26A11 as a potential therapeutic target for ischemic stroke.
Main Methods:
- Electrophysiological characterization of chloride currents in primary cultured neurons under various conditions.
- Assessment of SLC26A11 mRNA and protein expression following oxygen-glucose deprivation.
- In vivo evaluation of SLC26A11 inhibition in a rat stroke reperfusion model.
Main Results:
- SLC26A11 mRNA and protein levels were significantly upregulated in neurons under hypoxic conditions.
- Blocking SLC26A11 activity reduced chloride influx and attenuated neuronal swelling.
- SLC26A11 inhibition in a rat stroke model decreased infarct size and improved functional outcomes.
- SLC26A11 upregulation was observed in neurons near the infarct core in the animal model.
Conclusions:
- SLC26A11 acts as a critical chloride entry pathway contributing to neuronal swelling in stroke.
- Inhibition of SLC26A11 presents a promising novel therapeutic strategy for treating ischemic stroke.
